Envestnet Asset Management’s Altimmune ALT Stock Holding History

Envestnet Asset Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$172K	Buy	+56,743	New	+$169K	﹤0.01%	4671
2025 Q3	–	Sell	-32,908	Closed	-$127K	–	4511
2025 Q2	$127K	Buy	32,908 +10,671	+48%	+$57.7K	﹤0.01%	4309
2025 Q1	$111K	Buy	+22,237	New	+$141K	﹤0.01%	4222
2024 Q4	–	Sell	-19,084	Closed	-$117K	–	4301
2024 Q3	$117K	Sell	19,084 -8,732	-31%	-$59.2K	﹤0.01%	4111
2024 Q2	$185K	Sell	27,816 -8,717	-24%	-$64.3K	﹤0.01%	3953
2024 Q1	$372K	Buy	+36,533	New	+$372K	﹤0.01%	3611
2023 Q3	–	Sell	-30,986	Closed	-$109K	–	4009
2023 Q2	$109K	Buy	30,986 +7,984	+35%	+$35.8K	﹤0.01%	3823
2023 Q1	$97.1K	Buy	+23,002	New	+$273K	﹤0.01%	3799
2021 Q4	–	Sell	-15,168	Closed	-$172K	–	3868
2021 Q3	$172K	Buy	+15,168	New	+$184K	﹤0.01%	3528

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Asset Management's ALT Position: Q2 2026 in Review

Envestnet Asset Management opened a new position in Altimmune (ALT) in Q2 2026: 56,743 shares worth $172K. The stake represents ﹤0.01% of the portfolio and ranks #4671 among its holdings. This is a return to the name: Envestnet Asset Management previously reported a position in ALT as recently as Q2 2025.

Envestnet Asset Management first reported a position in ALT in Q3 2021 and has held it in 9 quarters since. The position peaked at $372K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Envestnet Asset Management held 56,743 shares of Altimmune worth $172K as of Q2 2026.
Altimmune was a new Envestnet Asset Management position in Q2 2026.
Altimmune made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4671 holding.
Envestnet Asset Management first reported a position in Altimmune in Q3 2021 and has held it in 9 quarters since.
Envestnet Asset Management's Altimmune position peaked at $372K in Q1 2024.
210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.